Effect of propranolol on mortality in patients with angina

Area of Science:

• Cardiology
• Pharmacology

Background:

• Angina pectoris is a common condition causing chest pain due to reduced blood flow to the heart.
• Ischemic heart disease management often involves medication to improve outcomes.

Purpose of the Study:

• To investigate the impact of beta-blocker treatment on myocardial infarction (MI) frequency and mortality.
• To compare outcomes in patients with angina pectoris receiving beta-blockers versus those who did not.

Main Methods:

• A three-year observational study of 217 general practice patients with angina pectoris.
• Comparison of annual infarct rates and mortality from MI between a group of 91 patients on beta-blockers and a group of 126 patients not on beta-blockers.
• Ensured comparability between groups regarding age, sex, blood pressure, and angina history.

Main Results:

• The annual infarct rate was over three times higher in patients not treated with beta-blockers compared to those who were.
• The annual death rate from myocardial infarction was nearly four times greater in the untreated group versus the beta-blocker group.
• Patients receiving beta-blocker therapy demonstrated significantly lower rates of infarction and associated mortality.

Conclusions:

• Beta-blocker therapy in patients with ischemic heart disease, including angina pectoris, substantially reduces the risk of myocardial infarction.
• Treatment including beta-blockade is associated with a significant decrease in mortality from myocardial infarction.
• These findings support the inclusion of beta-blockers as a key component in managing patients with ischemic heart disease.